The effect of omega-3 supplementation in COVID-19
Not Applicable
Recruiting
- Conditions
- COVID-19.COVID-19, virus identifiedU07.1
- Registration Number
- IRCT20151226025699N3
- Lead Sponsor
- Sabzevar University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Written consent for participation
Age over 34 years
A diagnosis of COVID-19 based on symptoms such as severe pneumonia, fever, fatigue, dry cough, respiratory distress, and lungs involvement in the computed tomographic (CT) scan according to the doctor's confirmation
Exclusion Criteria
Not tendency to continue participating in the study
Diagnosed cardiovascular and lung diseases which can disturb the study process
A diagnosis of malignant tumors
Recent use of chemotherapy drugs
Having incomplete medical records
Non-compliance with the omega-3 supplementation
Consumption of omega-3 fatty acids supplementation during the last 3-month before the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method